Description

Erlonat 150 mg (Erlotinib Hydrochloride)

🧴 Product Description
Targeted Therapy for Certain Types of Cancer

Erlonat 150 mg contains Erlotinib, a targeted anti-cancer medication classified as an EGFR (epidermal growth factor receptor) inhibitor. It works by blocking the action of the EGFR protein, which can promote the growth and spread of cancer cells. By inhibiting this receptor, Erlonat slows down tumor growth and helps control cancer progression.

Erlonat is primarily prescribed for:
• Non-small cell lung cancer (NSCLC) with EGFR mutations
• Pancreatic cancer (as part of combination therapy)
• Other cancers as determined by the oncologist

It is a prescription-only medication and should be used under strict supervision by a qualified healthcare provider.

Key Benefits:

Targeted Cancer Therapy: Acts specifically on EGFR-positive cancer cells.

Slows Tumor Growth: Reduces progression of lung and pancreatic cancers.

Oral Administration: Convenient once-daily dosing compared to some intravenous therapies.

Supports Combination Therapy: Can be combined with other treatments under medical supervision.

⚠️ Precautions

Is Erlonat 150 mg Right for You?

Before starting Erlonat, discuss your full medical history and medications with your oncologist.

Please inform your doctor if the patient:

Has Liver or Kidney Problems: Dose adjustment may be required.

Has Heart Conditions: Rare risk of cardiac events; monitor closely.

Is Pregnant or Breastfeeding: Not safe; can harm the baby. Use effective contraception.

Has Skin Conditions: May cause severe rash or dryness; inform your doctor about existing skin issues.

Is on Other Medications: Certain drugs (like warfarin or proton pump inhibitors) may interact with Erlonat.

Has Gastrointestinal Disorders: Can increase risk of diarrhea, nausea, or liver enzyme abnormalities.

⚡ Side Effects

Understanding Potential Reactions

Common side effects are often mild to moderate, but some can be serious.

Common Side Effects include:

• Rash or acne-like skin eruptions

• Diarrhea or nausea

• Loss of appetite

• Fatigue or weakness

• Cough or shortness of breath

Less Common Side Effects:

• Mouth sores or dry mouth

• Hair thinning

• Mild liver enzyme elevation

• Eye irritation or dryness

Serious Side Effects (Seek medical attention immediately):

• Severe skin reactions: blistering, peeling, or extensive rash

• Severe diarrhea leading to dehydration

• Liver dysfunction: jaundice, dark urine, severe abdominal pain

• Interstitial lung disease (rare but life-threatening)

• Allergic reactions: rash, swelling, difficulty breathing

Regular monitoring by your doctor is essential to detect side effects early.

🧪 How to Use

Guidelines for Safe and Effective Cancer Treatment

Dosage:
Typical starting dose: 150 mg orally once daily, or as prescribed by your oncologist.
The dose may be adjusted based on tolerance, side effects, or combination therapy.

Timing:
Take Erlonat at the same time every day, preferably on an empty stomach (at least 1 hour before or 2 hours after food).

Administration:

• Swallow the tablet whole with a glass of water.

• Do not crush, chew, or break the tablet.

• Avoid grapefruit or grapefruit juice while taking Erlonat, as it may interact with the medication.

• Continue taking Erlonat until your doctor advises otherwise, even if you feel well.

If You Miss a Dose:
Take it as soon as you remember. If it is almost time for your next dose, skip the missed dose. Do not double up.

Storage:

Store at room temperature, away from moisture and light.
Keep out of reach of children and pets.